Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

被引:39
作者
Bedi, G. [1 ]
Redman, J. [1 ]
机构
[1] Monash Univ, Dept Psychol, Melbourne, Vic 3004, Australia
关键词
cannabis; cognition; ecstasy; memory; polydrug;
D O I
10.1017/S0033291708002730
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Although there have been several reports linking ecstasy use with lowered cognitive function, much previous research suffers from substantial methodological limitations. The present study aimed to examine associations between ecstasy use and higher-level cognitive functions, using a larger sample size than most previous research and better controlling for a range of potential confounds. Method. A cross-sectional cohort design assessed 45 currently abstinent ecstasy polydrug users (EP), 48 cannabis polydrug users (CP) and 40 legal drug users (LD). Standardized neuropsychological tests were used to measure attention, verbal, visual and working memory and executive function. Prospective memory function was also assessed. Results. It was not possible to discriminate between groups on the basis of the cognitive functions assessed. Regression analyses showed an inverse association between lifetime dose of ecstasy and verbal memory performance. A combination of drug-use variables, including measures of ecstasy use, contributed to prediction of attention/working memory. However, individual associations were small, explaining 1-6% of variance in cognitive scores. Conclusions. Although the results suggest that heavy use of ecstasy is associated with some lowering of higher-level cognitive functions, they do not indicate a clinical picture of substantial cognitive dysfunction.
引用
收藏
页码:1319 / 1330
页数:12
相关论文
共 49 条
[1]   Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? [J].
Allott, Kelly ;
Redman, Jennifer .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03) :327-347
[2]   Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users [J].
Back-Madruga, C ;
Boone, KB ;
Chang, L ;
Grob, CS ;
Lee, A ;
Nations, H ;
Poland, RE .
CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) :446-459
[3]   MDMA-INDUCED NEUROTOXICITY - PARAMETERS OF DEGENERATION AND RECOVERY OF BRAIN-SEROTONIN NEURONS [J].
BATTAGLIA, G ;
YEH, SY ;
DESOUZA, EB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) :269-274
[4]   Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users [J].
Bedi, G ;
Redman, J .
JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (03) :432-436
[5]   Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment [J].
Bhattachary, S ;
Powell, JH .
PSYCHOLOGICAL MEDICINE, 2001, 31 (04) :647-658
[6]   Memory impairment in abstinent MDMA ("Ecstasy") users [J].
Bolla, KI ;
McCann, UD ;
Ricaurte, GA .
NEUROLOGY, 1998, 51 (06) :1532-1537
[7]   MDMA ('Ecstasy') and methamphetamine combined: Order of administration influences hyperthermic and long-term adverse effects in female rats [J].
Clemens, KJ ;
Cornish, JL ;
Li, KM ;
Hunt, GE ;
McGregor, IS .
NEUROPHARMACOLOGY, 2005, 49 (02) :195-207
[8]  
Cole J, 2002, PSYCHOLOGIST, V15, P464
[9]   The relative contributions of ecstasy and cannabis to cognitive impairment [J].
Croft, RJ ;
Mackay, AJ ;
Mills, ATD ;
Gruzelier, JGH .
PSYCHOPHARMACOLOGY, 2001, 153 (03) :373-379
[10]  
Eaton W. W., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1037/T29280-000